Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-034639
Filing Date
2025-04-14
Accepted
2025-04-14 15:34:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7602
  Complete submission text file 0001104659-25-034639.txt   9333
Mailing Address 2 INTERNATIONAL PLACE, 26TH FLOOR BOSTON MA 02110
Business Address 2 INTERNATIONAL PLACE, 26TH FLOOR BOSTON MA 02110 617.753.6400
Portolan Capital Management, LLC (Filed by) CIK: 0001350290 (see all company filings)

EIN.: 201926326 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546
Business Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 866-788-9007
CASTLE BIOSCIENCES INC (Subject) CIK: 0001447362 (see all company filings)

EIN.: 770701774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91094 | Film No.: 25835878
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)